The Hazelden Betty Ford Foundation Comprehensive Opioid Response (COR) training for non-prescribing professionals is designed to build foundational knowledge and practical skills for addressing opioid use disorder within a multidisciplinary care team. Part 2 of our COR Program introduces foundational concepts in harm reduction, medications for opioid use disorder (MOUD), and the lifesaving use of Naloxone.
This session is designed to equip participants with a practical understanding of these critical interventions.
Our trainers will address common myths and misconceptions about harm reduction and MOUD, and provide evidence-based insights aligned with the American Society of Addiction Medicine (ASAM) guidelines. We’ll also cover key information non-prescribers need to know about FDA-approved medications and offer strategies for effectively communicating about MOUD with patients across all levels of care.
Objectives:
- Explain the core principles of harm reduction and identify common myths and facts associated with its practice.
- Define intervention stigma and analyze its impact on clinicians, patients, and their families.
- Describe the role of FDA-approved medications in the treatment of opioid use disorder (OUD).
- Recognize the signs and symptoms of opioid overdose and demonstrate appropriate prevention and response strategies, including the use of Naloxone.